These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 551097)
1. Time in chemo-immunotherapy models: an absolute or a relative variable? Lessons from the levamisole experience. Amery WK Int J Immunopharmacol; 1979; 1(1):65-8. PubMed ID: 551097 [TBL] [Abstract][Full Text] [Related]
2. Chemo-immunotherapy with levamisole in metastatic breast carcinoma: a controlled clinical trial. Paterson AH; Edwards AM; Nutting M; Schinnour D; Takats L; McClelland A Cancer Clin Trials; 1980; 3(1):5-10. PubMed ID: 6993035 [TBL] [Abstract][Full Text] [Related]
9. Levamisole as an immunotherapeutic agent in the treatment of cancer. Amery WK World J Surg; 1977 Sep; 1(5):597-604. PubMed ID: 272084 [No Abstract] [Full Text] [Related]
10. Active non-specific immunotherapy of experimental tumours. Silobrcić V Folia Biol (Praha); 1980; 26(3):145-66. PubMed ID: 6998756 [No Abstract] [Full Text] [Related]
11. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole. Klefström P; Gröhn P; Heinonen E; Holsti L; Holsti P Cancer; 1987 Sep; 60(5):936-42. PubMed ID: 3300953 [TBL] [Abstract][Full Text] [Related]
12. Chemoimmunotherapy with levamisole during maintenance therapy in children with acute lymphoblastic leukemia. Bogusławska-Jaworska J; Raus Z Arch Immunol Ther Exp (Warsz); 1981; 29(6):719-23. PubMed ID: 6960810 [TBL] [Abstract][Full Text] [Related]
13. Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy. White JE; Chen T; Reed R; Mira J; Stuckey WJ; Weatherall T; O'Bryan R; Samson MK; Seydel HG Cancer Treat Rep; 1982 May; 66(5):1113-20. PubMed ID: 7044532 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of gastric cancer with levamisole. Miwa H; Orita K Acta Med Okayama; 1978 Oct; 32(5):363-7. PubMed ID: 153097 [TBL] [Abstract][Full Text] [Related]
16. Levamisole as adjuvant to chemotherapy for canine lymphosarcoma. MacEwen EG; Hayes AA; Mooney S; Patnaik A; Kurzman I; Hardy WD J Biol Response Mod; 1985 Aug; 4(4):427-33. PubMed ID: 3839843 [TBL] [Abstract][Full Text] [Related]
17. [Chemo-immunotherapy of acute myeloid leukemia with levamisole and 9 cytostatics]. Brincker H; Thorling K; Jensen B Ugeskr Laeger; 1977 Feb; 139(9):521-4. PubMed ID: 320739 [No Abstract] [Full Text] [Related]
18. [The effect of levamisole on non-resected lung cancer--the results of randomized controlled study]. Nishimura M; Morishita M; Urata A; Ota K Gan To Kagaku Ryoho; 1982 Nov; 9(11):1981-93. PubMed ID: 6307178 [TBL] [Abstract][Full Text] [Related]
19. Prophylaxis and therapy of an experimental bladder cancer with biological response modifiers. Morales A; Pang AS J Urol; 1986 Jan; 135(1):191-3. PubMed ID: 3941461 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of effects of levamisole and surgery on canine mammary cancer. MacEwen EG; Harvey HJ; Patnaik AK; Mooney S; Hayes A; Kurzman I; Hardy WD J Biol Response Mod; 1985 Aug; 4(4):418-26. PubMed ID: 4031952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]